Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer

Status: Recruiting

Location: See location...

Intervention Type: Behavioral

Study Type: Interventional

Study Phase: Not Applicable

SUMMARY

This research is being done to test a new communication tool for people with ovarian cancer, caregivers, and clinicians. The name of the intervention in this research study is: -Collaborative Agenda-Setting Intervention (CASI)

Eligibility

Participation Requirements

Sex: Female

Minimum Age: 18

Healthy Volunteers: f

View:

• At least 18 years old

• Able to speak, understand, and respond to questions written in English

• Willing to be audio recorded

• Have a diagnosis of advanced ovarian cancer (defined as stage III, stage IV, or recurrent disease)

• Be under the care of a participating clinician dyad

• Be scheduled for chemotherapy during the recruitment period

• Be signed up or willing to sign up for Patient Gateway

• At least 18 years old

• Able to speak, understand, and respond to questions written in English

• Willing to be audio recorded

• Be a family member, partner, or friend of a patient participant with whom the patient participant discusses their cancer care

• Be employed at DFCI as an oncologist, nurse practitioner, or physician assistant

• Take care of at least 4 patients per month with advanced ovarian cancer (defined as stage III, stage IV, or recurrent disease) in the outpatient setting

Locations

United States

Massachusetts

Dana-Farber Cancer Institute

RECRUITING

Boston

Contact Information

Primary

Rachel Pozzar, PhD

Rachel_Pozzar@DFCI.HARVARD.EDU

857-215-0743

Time Frame

Start Date: 2025-01-17

Estimated Completion Date: 2026-12-31

Participants

Target number of participants: 112

Treatments

Experimental: Arm 1: CASI Intervention

Enrolled patients and caregivers will complete:~* Audio recorded baseline visit~* CASI via mobile device, laptop, or desktop computer 1 week prior to CASI visit 1~* Audio recorded CASI visit 1~* CASI via mobile device, laptop, or desktop computer 1 week prior to CASI visit 2~* Audio recorded CASI visit 2~* CASI via mobile device, laptop, or desktop computer 1 week prior to CASI visit 3~* Audio recorded CASI visit 3~* End of study visit~For each enrolled patient, enrolled clinicians will complete:~* Audio recorded baseline visit~* Audio recorded CASI visit 1~* Audio recorded CASI visit 2~* Audio recorded CASI visit 3~Enrolled clinicians will also complete:~* Baseline visit, one time~* End of study visit, one time

No_intervention: Arm 2: Control

Enrolled patients and caregivers will complete:~* Audio recorded baseline visit~* Audio recorded visit 1 will proceed according to usual, oncology care~* Audio recorded visit 2 will proceed according to usual, oncology care~* Audio recorded visit 3 will proceed according to usual, oncology care~* End of study visit~For each enrolled patient, enrolled clinicians will complete:~* Audio recorded baseline visit~* Audio recorded visit 1 will proceed according to usual, oncology care~* Audio recorded visit 2 will proceed according to usual, oncology care~* Audio recorded visit 3 will proceed according to usual, oncology care~Enrolled clinicians will also complete:~* Baseline visit, one time~* End of study visit, one time

Related Therapeutic Areas

Ovarian Cancer

Similar Clinical Trials

View All

Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer

Similar Clinical Trials

Randomized Trial of REVITALIZE: A Telehealth Intervention to Reduce Fatigue Interference Among Adults With Advanced Ovarian Cancer on PARP Inhibitors

Randomized Trial of REVITALIZE: A Telehealth Intervention to Reduce Fatigue Interference Among Adults With Advanced Ovarian Cancer on PARP Inhibitors

Combined Intraperitoneal Chemotherapy Regimen After Optimal Interval Surgery in Advanced Ovarian Cancer: BICOV-1 (Bidirectional Chemotherapy in Ovarian Cancer)

Combined Intraperitoneal Chemotherapy Regimen After Optimal Interval Surgery in Advanced Ovarian Cancer: BICOV-1 (Bidirectional Chemotherapy in Ovarian Cancer)

Prehabilitation & Rehabilitation in Oncogeriatrics: Adaptation to Deconditioning Risk and Accompaniment of Patients' Trajectories-ovary/Elderly Women With Ovarian Cancer-2, a GINECO Multicenter Randomized Study (PROADAPT-ovary/EWOC-2)

Prehabilitation & Rehabilitation in Oncogeriatrics: Adaptation to Deconditioning Risk and Accompaniment of Patients' Trajectories-ovary/Elderly Women With Ovarian Cancer-2, a GINECO Multicenter Randomized Study (PROADAPT-ovary/EWOC-2)